Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab Users is a research paper published in Arthritis & Rheumatology (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01‐AR‐080659
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K23‐AR‐073334
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R03‐AR‐078938
NIAMS NIH HHS
Grant: K23 AR073334
NIAMS NIH HHS
Grant: R01 AR080659
NIAMS NIH HHS
Grant: R03 AR078938
NIAMS NIH HHS
Grant: R03-AR-078938
NIAMS NIH HHS
Grant: R01-AR-080659
NIAMS NIH HHS
Grant: K23-AR-073334
Rheumatology Research Foundation
MeSH Terms